GlassScriptPhysician profile
Lisa G Walker
NPI 1538120415
$16,884.53
in general payments reported to CMS, 2019-2025
48 companies · $3,658 in 2025
The $3,658 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,707 · 2022: $3,118 · 2023: $3,973 · 2024: $3,429 · 2025: $3,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,059.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,946.97 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $1,586.20 | 2021-2025 | Xarelto, Spravato |
| Abbvie INC. | $1,477.34 | 2021-2025 | |
| Novo Nordisk INC | $1,378.98 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,086.28 | 2021-2025 | Repatha, Otezla, Krystexxa |
| Abbott Laboratories | $940.66 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3, Jot Dx |
| Novartis Pharmaceuticals Corporation | $811.25 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $710.05 | 2021-2025 | Xifaxan |
| Janssen Biotech, INC. | $709.29 | 2021-2025 | Tremfya |
| Lilly USA, LLC | $686.48 | 2021-2025 | Jardiance, Zepbound, Emgality |
| Ani Pharmaceuticals, INC. | $374.85 | 2024-2025 | Purified Cortrophin Gel |
| Esperion Therapeutics, INC. | $361.91 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $355.60 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Merck Sharp & Dohme LLC | $317.59 | 2021-2025 | Verquvo, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $297.50 | 2022-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $260.37 | 2021-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $222.94 | 2021-2024 | Camzyos |
| Pfizer INC. | $199.36 | 2021-2025 | |
| Glaxosmithkline, LLC. | $195.26 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Phathom Pharmaceuticals, INC. | $164.10 | 2024 | Voquezna |
| Lexicon Pharmaceuticals, INC. | $160.38 | 2023-2024 | Inpefa |
| Idorsia Pharmaceuticals US INC | $151.76 | 2022-2025 | Quviviq, Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $151.23 | 2022 | |
| Vifor Pharma, INC. | $148.01 | 2023 | Veltassa, Korsuva |
| Amarin Pharma, INC. | $133.97 | 2021 | |
| Gilead Sciences, INC. | $112.35 | 2025 | Epclusa |
| Xeris Pharmaceuticals, INC. | $99.86 | 2023-2024 | Keveyis, Gvoke Hypopen |
| Horizon Therapeutics Plc | $99.61 | 2023 | Tepezza, Krystexxa |
| Actelion Pharmaceuticals US, INC. | $85.95 | 2021 | |
| Impel Pharmaceuticals INC. | $82.72 | 2023 | Trudhesa |
| Dexcom, INC. | $60.44 | 2023-2024 | Dexcom G6 Transmitter |
| Scpharmaceuticals INC. | $57.20 | 2025 | |
| Corcept Therapeutics | $53.63 | 2025 | Korlym |
| Philips North America LLC | $50.89 | 2024 | (5044) Mcot |
| Paratek Pharmaceuticals, INC. | $44.67 | 2022-2023 | Nuzyra |
| Axonics, INC. | $41.33 | 2023-2024 | Axonics |
| Takeda Pharmaceuticals U.S.A., INC. | $33.88 | 2021-2023 | Aralast |
| Boston Scientific Corporation | $32.57 | 2024-2025 | General - Therapies |
| Axsome Therapeutics, INC. | $30.35 | 2025 | Auvelity |
| Medicomp INC | $27.99 | 2023 | Telepatch Cardiac Monitor |
| Sanofi-Aventis U.S. LLC | $27.36 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $18.69 | 2023 | Assure Wcd |
| Heartflow, INC. | $18.47 | 2024 | |
| Allergan, INC. | $18.31 | 2021 | |
| Bardy Diagnostics, INC. | $16.99 | 2022 | |
| Advanced Oxygen Therapy INC. | $15.97 | 2024 | Topical Oxygen Chamber For Extremities |
| Kowa Pharmaceuticals America, INC. | $13.72 | 2022 | |
| Biodelivery Sciences International, INC. | $13.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.